Failure of the canine principal ascending epicardial lymphatic to regenerate after transection

Lymphology

Volumn 32, Issue 1, 1999, Pages 29-35

  Miller, Albert J ^a   Palmer, A S ^a   Eliska, O ^b   Eliskova, M ^b   DeBoer, A ^a   Greene, R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; COLLATERAL CIRCULATION; CORONARY ARTERY BYPASS GRAFT; DOG; EPICARDIUM; FEMALE; HEART TRANSPLANTATION; LYMPH FLOW; LYMPHATIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; REGENERATION;

ANIMALS; DOGS; FEMALE; LYMPHATIC SYSTEM; MALE; PERICARDIUM; REGENERATION;

EID: 0032948276     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Patek, PR: The morphology of the lymphatics of the mammalian heart. Am. J. Anat. 64 (1939), 203-249.
2. Drinker, CK, JM Yoffey: Lymphatics, Lymph and Lymphoid Tissue. Harvard University Press, Cambridge, 1941.
3. Miller, AJ: The Lymphatics of the Heart. Raven Press, New York City, 1982.
4. Rusznyák, I, M Földi, G Szabó: Lymphatics and Lymph Circulation. Pergamon Press, New York, 1960.
5. Drinker, CK, ME Field, FW Mauner, et al: The flow, pressure, and composition of cardiac lymph. Am. J. Physiol. 130 (1940), 43-55.
6. Sun, SC, JT Lie: Cardiac lymphatic obstruction: Ultrastructure of acute-phase myocardial injury in dogs. Mayo Clin. Proc. 52 (1977), 785-792.
7. Miller, AJ, R Pick, PJ Johnson: The rates of formation of cardiac lymph and pericardial fluid after the production of myocardial venous congestion in dogs. Lymphology 5 (1972), 156-160.
8. Ludwig, LL, ER Schertel, JW Pratt, et al: Impairment of cardiac function by acute cardiac lymphatic obstruction. Cardiovasc. Res. 33 (1997), 164-171.
9. Pardo Mindan, FJ, A Panizo, MD Lozano, et al: Role of endomyocardial biopsy in the diagnosis of chronic rejection in human heart transplant. Clinical Transplantation 11 (1997), 426-431.
10. Mousseaux, E, D Farge, R Guillemain, et al: Assessing human cardiac allograft rejection using MRI with Gd-DOTA. J. Computer Assisted Tomography 17 (1993), 237-244.
11. Sueda, T, Y Matsuura, T. Matsushima, et al: A heterotopic cardiac transplantation model for evaluation of rejection using transvenous endomyocardial biopsy. Hiroshima J. Med. Sciences 39 (1990), 15-18.
12. Sasaguri, S, M Sunamori, K Saito, et al: Early change of myocardial water during acute cardiac allograft rejection. Japanese Circulation J. 50 (1986), 1113-1119.
13. Cunningham, MJ, RC Paternak: The potential role of viruses in the pathogenesis of atherosclerosis. Circulation 77 (1988), 964-966.
14. Gupta, S, EW Leatham: The relation between Chlamydia pneumoniae and atherosclerosis. Heart 77 (1997), 7-8.
15. Muhlestein, JB, EH Hammond, JF Carlquist, et al: Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J. Amer. Coll. Cardiol. 27 (1996), 1555-15561.
16. Linnanmaki, E, M Leinonen, K Mattila, et al: Presence of Chlamydia pneumoniae specific antibodies in circulating immune complexes in coronary heart disease. Circulation 87 (1993), 1130-1134.
17. Kuo, CC, A Shor, LA Campbell, et al: Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167 (1993), 841-849.
18. Jackson, LA, LA Campbell, RA Schmidt, et al: Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: Evaluation of the innocent bystander hypothesis. Am.J. Path. 150 (1997), 1785-1790.
19. Miller, AJ, A DeBoer, AS Palmer: The role of the lymphatic system in coronary atherosclerosis. Medical Hypotheses 37 (1992), 31-36.
20. th Edition). University Press, Oxford, 1971.